Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7269 p449
4 October 2003

This page
Reprint
Photocopy

   

PDF* 90K

Letters

  Prescription charges
  Community pharmacy
  Medical research
  Remuneration
  Advertising
  Primary care
  Fluoridation
  The Society


Letters to the Editor

The Society

How justified is the workforce census?

From Mr P. Jenkins, FRPharmS

There is to be another pharmacy workforce census in 2003 but how justified is this exercise? Against the arguments that all knowledge is useful and baselines are needed to detect trends there can be no disagreement, but having gathered all the facts what will the Royal Pharmaceutical Society do with them to justify the cost? As for workforce planning, apart from the small number of pharmacists the Society directly employs it has no power to direct labour either across the country or from one type of work to another. It will be the schools of pharmacy together with the new primary care authorities in the various countries that will, in time, solve the manpower shortage.

For the Society it may seem an impressive exercise to do a major trawl for information but apart from neatness and the appearance of action there are other, less dramatic, ways of getting useful facts more conveniently, and at less cost.

When the information is collated it has to be sent to the departments that can use it — but why that way round?

For example, the education division needs certain facts to ensure the continuing professional development portfolios being returned are relevant to practitioners’ work, so it requests personal details when people register and can ask for more when the returns are submitted. The same applies with all membership groups and wherever the Society contacts the membership in mass. There is also the request for information on our age, sex, address and field of practice when we make our yearly registration returns, and these are analysed.

So before deciding to have a census as such, why not decide what facts can be useful, given the Society’s limited powers, and ask relevant questions each year within established necessary mailings so that the information will go straight to the department that will use it.

To avoid duplication of effort and for the sake of economy, realism and continuity these processes are worth considering and putting in place for the future.

Peter Jenkins
Cardiff

 

ZOE WHITTINGTON, practice research manager, Royal Pharmaceutical Society, replies:

Influencing national education and health policy forms a central part of the Society’s professional leadership function. As workforce planning is a key theme in both policy areas the collection and careful analysis of workforce data for pharmacy is a core activity for the Society. The data from the 2002 Pharmacy Workforce Census has already been used in responding to the recent debate about the Office of Fair Trading proposals on control of entry.

Information generated from the 2002 Pharmacy Workforce Census has been made publicly available through the Society’s website and a series of articles has been published in The Pharmaceutical Journal. Relevant stakeholders, both internally and externally, have been fully briefed about the findings. Specifically, the information from the census and other follow-up research is being used to inform the roll-out of continuing professional development and specific analyses have been undertaken and presented to the Society’s Scottish and Welsh Executives.

Before the decision to undertake a workforce census in 2002, extensive consultation with relevant stakeholders identified the key data that needed to be collected. The 2003 data will be compared with the 2002 data and the extent of in-year changes quantified. In the light of this the frequency of future census exercises will be agreed as will the method of data collection.

We have received over 14,500 responses to date (38 per cent) and would like to thank those pharmacists who have returned their census forms. Clearly the higher the response rate the higher the quality and usefulness of the data. If we are to inform policy effectively it is important that our data are as comprehensive as possible.

Send your letter to The Editor

Previous Topic (Fluoridation)

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal